There is no central funding in GeCIP. GeCIP domains will need to show they have the resources or clear plans for obtaining the resources to do the work they intend to carry out. Genomics England cannot award grants to GeCIP domains – we are providing the data centre, 100,000 whole genome sequences and associated clinical data and a multi-omic sample repository.
Tell us if you are planning to submit a research proposal
Applications for funding should be registered with us. We will be able to offer a letter of support for your application. We strongly encourage trainees to contact us when considering fellowship or grant applications. Please allow at least 1 month for Genomics England to review your proposal.
Funding for GeCIP research projects
Researchers wanting to undertake research through GeCIP will need to apply to a funding body through response mode or specific funding calls that are targeted at using the 100,000 Genomes Project dataset. These applications will be subject to approval via the scientific peer review process by funders. Details of any specific calls will be announced on these pages and in the GeCIP newsletter.
The Wellcome Trust have expressed an interest in seeing funding applications from GeCIP members, particularly for their collaborative awards.
Medical Research Council
The Medical Research Council would be happy to receive applications from GeCIP members through any of their funding schemes.
The Industrial Strategy Challenge Fund
As part of the UK Industrial Strategy, the government will invest up to £20m in the Next Generation Services Industrial Strategy Challenge Fund. The challenge will include an initial CR&D call of up to £12m and an initial Research Programme call of up to £3m.
The next-generation services challenge fund is delivered by Innovate UK, as part of UK Research and Innovation.
US Food and Drug Administration – Open Call for Grant Applications
It may be of interest to UK researchers that the US Food and Drug Administration (FDA) has an open grant call for $2m for studies investigating the natural history of rare diseases. The grants are designed to help characterize the natural history of rare diseases, identify subpopulations, and develop and/or validate clinical outcome measures, biomarkers and companion diagnostics.
Grants are available to any foreign or domestic, public or private, for-profit or non-profit entity. Funding can include research being performed at foreign sites; all or part of the funding can be used to support foreign clinical study sites. For more information see the FDA website.
The GeCIP board
The Genomics England Clinical Interpretation Partnership is overseen by the GeCIP Board, chaired by Professor Dame Kay Davies.
The GeCIP board includes representatives from several funding bodies who have already substantially contributed to the work of Genomics England, through the pilot phase of the project or investment in infrastructure. The GeCIP board will be informed of funding applications under development.